SCHEMBL2132525

SCHEMBL2132525

C[C@H](NCC(=O)O)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
PTGS2 P35354 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ECE1 P42892 1/20 0.38
CYP1A2 P05177 1/20 0.37
MME P08473 2/20 0.36
ACE P12821 2/20 0.36
CPA1 P15085 2/20 0.36
ACE2 Q9BYF1 2/20 0.36
TP53 P04637 1/20 0.36
CTH P32929 1/20 0.36
EGLN1 Q9GZT9 1/20 0.34
LTA4H P09960 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1700840 1.00 ALDH1A1 (0.43) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL2805307 1.00 ALDH1A1 (0.43) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL14056387 0.97 ALDH1A1 (0.41) ALDH1A1LMNAMAPTPTGS2TDP1
Hydrochloric Acid SCHEMBL10578120 0.97 ALDH1A1 (0.41) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL667846 0.97 ALDH1A1 (0.41) ALDH1A1LMNAMAPTPTGS2TDP1
Boric Acid SCHEMBL31168108 0.93 ALDH1A1 (0.39) ALDH1A1LMNAMAPTPTGS2TDP1
Alanine SCHEMBL27729429 0.91 ALDH1A1 (0.38) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL5960119 0.89 BHMT (0.37) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL28627379 0.85 EGLN1 (0.35) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL3442583 0.82 ALDH1A1 (0.36) ALDH1A1LMNAMAPTPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 336 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025109003-A1 P-CADHERIN LIGANDS 3B PHARMACEUTICALS GMBH (DE) 2025-05-30 WO claimed
US-20230271892-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES SOLUGEN, INC. (US) 2023-08-31 US claimed
EP-3189116-B1 SLICK-WATER FRACTURING USING TIME RELEASE METAL-COMPLEXING AGENT FLEX CHEM HOLDING COMPANY LLC (US) 2023-08-09 EP claimed
EP-4188074-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES Solugen, Inc. (US) 2023-06-07 EP claimed
WO-2022115283-A1 METHOD FOR IMPROVED OIL RECOVERY IN SUBTERRANEAN FORMATIONS WITH CIRCUMNEUTRAL PH FLOOD HALLIBURTON ENERGY SERVICES, INC. (US) 2022-06-02 WO claimed
US-20220162498-A1 METHOD FOR IMPROVED OIL RECOVERY IN SUBTERRANEAN FORMATIONS WITH CIRCUMNEUTRAL pH FLOOD HALLIBURTON ENERGY SERVICES, INC. 2022-05-26 US claimed
US-11332658-B2 Stimulation of wells in nano-darcy shale formations FLEX-CHEM HOLDING COMPANY, LLC (US) 2022-05-17 US claimed
US-11224222-B2 Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions ISP INVESTMENTS LLC (US) 2022-01-18 US claimed
CN-107613954-B Synergistic compositions of dehydroacetic acid and methods of reducing yellowing in various end-use compositions ISP投资有限公司 2021-10-19 CN claimed
US-11084971-B2 Acidizing treatment fluids for use in subterranean formation operations HALLIBURTON ENERGY SERVICES, INC. (US) 2021-08-10 US claimed
US-20120115759-A1 TREATMENT FLUIDS CONTAINING A BORON TRIFLUORIDE COMPLEX AND METHODS FOR USE THEREOF HALLIBURTON ENERGY SERVICES, INC. (US) 2012-05-10 US claimed
US-20120097392-A1 Treatment Fluids Containing Biodegradable Chelating Agents and Methods for Use Thereof HALLIBURTON ENERGY SERVICES, INC. (US) 2012-04-26 US claimed
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT L'OREAL (FR) 2010-10-28 US claimed
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS L'OREAL (FR) 2010-09-23 US claimed
WO-2010100589-A1 TASTE MODIFYING COMPOUND FIRMENICH SA (CH) 2010-09-10 WO claimed
EP-2207525-A2 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT METHOD L'Oréal (FR) 2010-07-21 EP claimed
EP-2205201-A2 COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING A POLYCONDENSATE, POLYCONDENSATE AND COSMETIC TREATMENT METHOD L'Oreal (FR) 2010-07-14 EP claimed
WO-2009053594-A2 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2009-04-30 WO claimed
WO-2009053587-A2 COMPOSITION CONTAINING A POLYCONDENSATE, POLYCONDENSATE AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2009-04-30 WO claimed
WO-2009053584-A2 COSMETIC OR PHARMACEUTICAL COMPOSITION CONTAINING A POLYCONDENSATE, POLYCONDENSATE AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2009-04-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239509-A1 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS CUTA, SUCLG1, KRT18 ALDH1A1 1901/4885LMNA 1561/4885MAPT 2575/4885
US-20100272660-A1 COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT ACMSD, CUTA, PCCA ALDH1A1 1510/4885LMNA 833/4885MAPT 3115/4885
US-11224222-B2 Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions ALAD, SCD, DHCR7 ALDH1A1 92/4885LMNA 825/4885MAPT 2152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.